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Abstract
Background: Ototoxicity refers to damage of the cochlea and/or vestibular apparatus from exposure to chemical 
substances, resulting in hearing impairment and or disequilibrium. An earlier study carried out at University of Benin Teaching 
Hospital (UBTH) in 2000 implicated chloramphenicol as the commonest ototoxic drug, followed by antimalarials (Quinine).
Aim: To identify the commonly implicated drugs in patients diagnosed with ototoxicity in Ear, Nose and Throat (ENT) 
Clinic of UBTH.
Materials and Methods: One-hundred and three patients’ case notes, diagnosed as having ototoxicity, between June 
2005 and July 2010 at the ENT Clinic of UBTH were reviewed. Seventy-nine cases met the criteria for diagnosis of 
ototoxicity in this study.
Results: Intravenous quinine (19.0%) was the commonest implicated drug, followed by oral chloroquine (6.3%), 
antihypertensive drugs (nifedipine, moduretics, artenolol [6.3%]), native herbal medicine (13.9%), chloramphenicol 
(1.3%), and unidentifiable drugs accounted for 53.2%. Most patients had severe to profound hearing loss at 4000 Hz 
and at 8000 Hz. Tinnitus was found in 84.8% of the patients.
Conclusion: Quinine is still the commonest implicated ototoxic drug in this part of the country.
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Introduction
Ototoxicity refers to damage of the cochlea and/or vestibular 
apparatus from exposure to chemical substances, resulting in 
hearing impairment and/or disequilibrium. Ototoxicity may 
be reversible or irreversible. It is different from neurotoxicity 
where the site of action of the drug is on the central nervous 
system (i.e. on the cranial nerve VIII). Ototoxicity came to 
forefront in 1944 when streptomycin was discovered to have 
caused hearing and vestibular disequilibrium in patients where 
it was used to treat tuberculosis (Kahlmet 1984).[1] Quinine 
therapy was also found to be associated with hearing loss, 
tinnitus, and disequilibrium for more than two centuries.[2] 
Since then, other drugs like aspirin, calcium channel blockers, 
moduretic, cisplatin, etc, were added onto the ototoxic drug 
list.[3-6] [Table 1]. The mechanism of oto- and vestibular 
toxicity has been elusive. Mechanisms for acute and chronic 
toxicity may be different. Blood quinine levels of 0.2 mg/mL 
found in pilots who died in aviation accidents suggested that 
quinine toxicity may have played a causative role.[7] Ototoxic 
effect of quinine is due to vasoconstriction in the small vessels 
of the cochlea and stria vascularis. Prolonged administration 
of high-dose quinine in many patients led to loss of outer hair 
cells. There may also be an effect on cochlear blood flow.[8]
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Aminoglycosides cause selective destruction of the outer hair 
cells, starting from the basal coil and progressing onto the 
apex of the cochlea. The incidence of clinical and functional 
hearing loss due to aminoglycosides has been significantly 
diminished because some of the newer derivatives have 
lower ototoxic potential and, perhaps, efficient monitoring 
of serum levels of drugs has allowed for better dosing 
schedules. However, the problem is a significant one as they 
are still widely used in the treatment of serious gram-negative 
infections as pointed out by Schacht.[9] In 1979, Mukhajee and 
Mukhajee reported antimalarials as the commonest cause of 
ototoxicity.[10] However, there is paucity of literature on the 
prevalence of ototoxicity in Nigeria. In 2000, F. O. Ogisi in 
a prospective study of 49 patients with ototoxicity at ENT 
Clinic of University of Benin Teaching Hospital (UBTH) 
reported that chloramphenicol was the commonest ototoxic 
drug, incriminated in 43% of their patients.[11]
Aim of the study
To identify the ototoxic drugs currently responsible for 
ototoxicity at UBTH.
Materials and Methods
This study was a review of patients who presented at UBTH 
with a history of hearing loss following drug intake. The 
patients were assessed based on the type of drugs they took 
and/or were taking within the 3 weeks he or she noticed the 
hearing loss. The route and the length of period the drug 
was being taken were also considered. The patient’s type 
and degree of hearing loss were obtained where possible 
because infants less than 4 years could not give a reliable 
PTA (pure tone audiometry) response. The illness that 
resulted in the intake of the accused drug was also reviewed. 
Out of 6420 patients seen in ENT Clinic of UBTH between 
June 2005 and July 2010, 103 patients were diagnosed as 
having ototoxicity. Out of the 103 patients diagnosed as 
having ototoxicity, only 79 of them met the criteria for this 
study. Inclusion criteria for this study include patients who 
presented with sudden or progressive hearing loss of less 
than 3 weeks’ duration following drug intake for any illness 
and patients who did pure tone audiometry following the 
hearing loss. However, children below 5 years of age were 
assessed using distraction test because most of them could 
not give a reliable pure tone audiometric response. Patients 
with previous history of hearing impairment from any other 
cause and patients with incomplete data were excluded 
from the study.
Results
The results of 79 patients were analyzed. There were 
40 males and 39 females. The age ranged from 6 months to 
Table 1: List of drugs causing hearing impairment and/or balance problems
Aminoglycosides Gentamicin, streptomycin, kanamycin, amikacin, tobramycin, neomycin, netilmicin, polymyxin-B
Macrolides Erythromycin, azithromycin, clarithromycin
Loop diuretics Furosemide, bumetanide, ethacrinic acid
Salicylates
Antimalarials Quinine, chloroquine (high dosage)
Non-steroid anti-inflammatory drugs Naproxen, indomethacin (no definite findings)
Anti-neoplastic drugs Cisplatin, bleomycin, carboplatinum
Chelating agents Desferoxamine











2% acetic acid solution (?)
Chemical agents Heavy metals
Solvents
Others
Mercury, lead (Industrial pollution, cosmetics).
Toluene, styrene
Arsenic, cobalt, cyanides, benzene,
propylene-glycol, potassium bromide
455Nigerian Journal of Clinical Practice • Oct-Dec 2012 • Vol 15 • Issue 4
Obasikene, et al.: Prevalence of ototoxicity in UBTH
70 years, with a mean age of 31–40 years and STD ± 1.89.
The commonest affected age group was 20–30 years (21.5%) 
while the least affected age was less than 1 year (1.3%) 
[Figure 1]. Majority of the patients (84.8%) had tinnitus. 
Others stated either they did not have tinnitus (3.8%) or 
could not say whether they have tinnitus or not (11.4%). 
The treatment outcome showed that 82.3% absconded 
from treatment and 10.1% had no improvement while 
only 7.6% got better. The commonest implicated drug was 
quinine (19%) followed by native herbal medicine drugs 
(13.9%). Other implicated drugs were chloroquine (6.3%), 
antihypertensives (6.3%), chloramphenicol (1.3%), and 
others (53.2%). All the patients had severe-to-profound 
hearing loss on both high and low frequencies.
Discussion
The study showed that almost all age groups were affected 
but people in their most productive years of life (15– 49 years) 
had the highest (51.9%) incidence of ototoxicity, followed by 
children below 10 years old [Table 2].[12] The elderly patients 
and infants below 1 year were the least affected though 
assessing the type and degree of hearing loss in patients of 
less than 4 year was difficult, especially without otoacoustic 
emission. In this study, children of less than 4 years were 
assessed by verbal speech and distraction method.
The commonest illness that necessitated the intake of 
the offending drug was malaria, followed by febrile illness. 
However, most of the diagnoses and treatment were made in 
peripheral hospitals and by non-experts. All patients in this 
study live in a malaria endemic area. Young adults are known 
to suffer drug-resistant malaria compared to infants).[13] 
Other studies also showed that young adults are worst hit 
by malaria.[14,15] It has been documented that about 95–99% 
of the adult population carry the malaria parasite with less 
than 30% of this number coming down with illness.[16] This 
could partially explain the higher incidence of ototoxicity 
seen in young adults. The commonest implicating substance 
in our study was intravenous quinine [Table 3]. In 2000, 
a similar study by Ogisi et al. in the same center revealed 
quinine to be the 2nd most common cause of ototoxicity 
after chloramphenicol.[11] During that period, typhoid fever 
was treated most commonly with chloramphenicol. Today, 
because of the awareness of the ototoxicity and other side 
effects of the drug, it has been replaced by ciprofloxacin and 
other safer antibiotics.
This study, however, found quinine to be the commonest 
offending drug, which is not unexpected in a malaria 
endemic area like Nigeria, especially where quinine is 
mostly used in the treatment of resistant and cerebral 
malaria.[17] Tinnitus was present and bilateral in 84.8% of 
all the patients [Table 4]. Tinnitus is one of the commonest 
side effects of quinine, which is the most common drug 
used in treatment of drug-resistant malaria. Because only 
19% of patients in this study took quinine, other drugs are 
also implicated for this high percentage of tinnitus noted 
in the study.
One of the major determinants for choice of treatment is 
the most affordable drugs, usually not the safest.[18] Quinine 
being one of the most available and affordable drugs, when 
other cheap drugs for resistant malaria have failed, will 
Figure 1: Age histogram
Table 2: Age frequency
Age in years Frequency Percent
<1 yr 1 1.3
1–10 yrs 11 13.9
11–20 yrs 11 13.9
21–30 yrs 17 21.5
31–40 yrs 12 15.2
41–50 yrs 12 15.2
51–60 yrs 7 8.9
61–70 yrs 8 10.1
Total 79 100.0
Table 3: Frequency of implicated drugs





Native herbal medicine 11 13.9
No idea 42 53.2
Total 79 100.0
Table 4: Frequency of tinnitus
Frequency Percent
Tinnitus 67 84.8
No tinnitus 3 3.8
Not clear 9 11.4
Total 79 100.0
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continue to dominate in the hands of non-medical experts 
for treatment of resistant malaria. It has also been reported 
that sub-standard drugs are readily available. In a study 
in two developing countries for instance, of 96 samples of 
chloroquine collected from Nigeria and Thailand for analysis, 
the results indicated that 36.5% were sub-standard.[19] Not 
only does this imply discrepancies in clinical studies, but 
this may, in itself, be a cause of ototoxicity in developing 
countries. The 53% who had no idea of the drugs given to 
them and could not fix their hearing loss to any cause may 
be due to the problems of a developing country [Table 5]. 
This problem includes low or no education, which denies 
an individual the power to know, lack of funds or facility 
to diagnose or seek medical attention, and patients having 
little or no knowledge of the drugs given to him.[20-22] 
13.9% were on native herbal medicine. Herbal medicine 
was introduced into National Health Service (NHS) many 
years ago. It started when the Royal London Homeopathic 
Hospital (RLHH), founded in 1849, joined the National 
Health Service (NHS) at its inception in 1948 and became 
part of University College Hospitals NHS Foundation Trust 
(UCLH), one of the UK’s leading academic medical centers, 
in 2003. Despite its title, it offers a range of complementary 
medicine (CM) services, not only homeopathy. Until 
around 1980, it was a small general hospital with a specialist 
homeopathic department. The surgical and other facilities 
were replaced by a range of CM services including the 
NHS’s first complementary cancer (1960), acupuncture 
(1977), autogenic training (1986), musculoskeletal (1993), 
herbal medicine services (2008), and others.[23] Many people 
mistakenly think that all medicinal herbs, being natural, are 
generally safe and free from undesirable side effects while 
acting as an effective agent. However, very often, herbs may 
interact with medications that result in adverse effects. The 
use of herbal medicine is still poorly understood by the public. 
Nowadays, toxicity and safety of medicinal herbs is one of 
the most discussed topics as herbal products have become 
popular in the developed and developing countries.
More research work is needed on ototoxic drugs, 
especially among the 53% who had ototoxicity but were 
not able to identify the drugs they were given. 6.3% of 
both antihypertensives and chloroquine and the 1.3% 
of the chloramphenicol are equally of great importance, 
considering the population on these drugs and at the risk of 
developing ototoxicity. These drugs are also in the ototoxic 
drug list.[24] Over 80% of patients were lost to follow-up; 
this could be because they were not getting better or that 
Table 5: Treatment outcome Frequency
After treatment Frequency Percent
Improvement 6 7.6
No improvement 8 10.1
Absconded 65 82.3
Total 79 100.0
they could not afford the cost of their treatment. The 
severe-to-profound hearing loss seen in all the patients could 
also be attributed to the problems of the developing world 
where medical attention is not sort on time because of lack 
of funds and unavailability of specialists in many places.
Conclusion
Quinine has been found to be the commonest ototoxic 
drug in our environment. As part of a health campaign to 
prevent quinine ototoxicity, quinine should be prescribed 
with caution, and if possible, with audiometric and quinine 
serum level monitoring. There should be a drug policy 
guiding the dosage prescription and potency of herbal drugs. 
Above all, the side effects of herbal drugs must be specified 
on the drug container. There should be an unrelenting effort 
to get the best alternative to drugs with unavoidable severe 
side effects and a health policy that can give everybody the 
opportunity of receiving good health care, irrespective of the 
patients’ financial status. Also, a massive health campaign 
on side effects of drugs and herbal medicine should be made 
to all primary healthcare providers, patent medicine dealers, 
herbalists, homeopaths, and pharmacists.
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